Issue 9 of the American Association of Clinical Endocrinologists’ (AACE) peer-reviewed journal, Endocrine Practice, features new clinical practice guidelines and an algorithm to help aid in the treatment of postmenopausal osteoporosis.
The AACE/American College of Endocrinology (ACE) clinical practice guidelines are to assist physicians and other medical professionals with the diagnosis, fracture risk assessment, and treatment of postmenopausal osteoporosis patients, according to a media release from AACE.
“With the increasing impact of postmenopausal osteoporosis on quality and quantity of life as our citizens age, it is imperative that we offer efficient, effective evaluation and treatment for those who may be suffering from this devastating disease,” says Pauline Camacho, MD, FACE, co-chair of the AACE Osteoporosis Task Force and AACE President, in the release. “These guidelines incorporate the latest evidence and expert opinion to offer physicians, regulatory bodies and interested laypersons the information needed to reduce the risk of osteoporosis-related fractures.”
“Increasingly there has been concern about prolonged use of bisphosphonates and rare adverse events such as osteonecrosis of the jaw and atypical femoral fractures,” she adds. “The guidelines will have recommendations on the duration of therapy based on severity of osteoporosis and fracture risk. We hope these recommendations will guide clinicians in the long-term care of osteoporosis patients.”
[Source(s): American Association of Clinical Endocrinologists, Business Wire]
